Recordati Rare Diseases North America
Philip Moore is an experienced professional in the pharmaceutical and healthcare industries, currently serving as a Rare Disease Manager in Haematology/Endocrinology at Recordati Rare Diseases Inc. since November 2022. With a solid background in sales and territory management, Philip has held various positions, including Specialist Sales Representative at Fresenius Kabi, Hospital Specialist Representative roles at Viatris and SUN PHARMA, and GP Medical Representative at GSK. Philip's expertise spans across managing portfolios for areas such as COPD, vaccines, dermatology, diabetes devices, and topical anaesthetics. Academic credentials include a Bachelor of Formulation Science (Honours) from Monash University, complemented by an Honours in Formulation Science from the Victorian College of Pharmacy.
This person is not in the org chart
This person is not in any offices
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.